Author

Özcan Met

Herlev HospitalORCID 0000-0002-3256-7592Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Assay:flow cytometry· 1

Frequent Co-Authors

A.-C. Kiel Rasmussen· 1 shared André RosaiD· 1 shared Carlos‐Filipe PereiraiD· 1 shared Charlotte VeseriD· 1 shared Christopher Aled ChamberlainiD· 1 shared David AskmyriD· 1 shared David Leander Petersen· 1 shared Emilie RenaudiD· 1 shared

Activity by Year

2024-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A.-C. Kiel Rasmussen

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Analyzing functional heterogeneity of effector cells for enhanced adoptive cell therapy applications

A.-C. Kiel Rasmussen, Thomas Morgan Hulen, David Leander Petersen, Mette Juul Jacobsen, Marie Just Mikkelsen, Özcan Met, Marco Donia, Christopher Aled Chamberlain, Peter Mouritzen

The paper demonstrates the use of double-emulsion droplet technology to analyze single-cell effector function in adoptive cell therapy, enabling high-resolution study of cell-cell interactions and functional heterogeneity.

Immuno-Oncology Technology · Sep 25, 2024Peer-reviewedImmunology

A cancer immunotherapy modality based on dendritic cell reprogramming in vivo

Ervin Ascic, Malavika Sreekumar Nair, André Rosa, Ilia Kurochkin, Olga Zimmermannová, Nadezhda Rotankova, Charlotte Veser, Tommaso Ballocci, Tiffany Schärer, Xiaoli Huang, Emilie Renaud, Marta Velasco Santiago, Özcan Met, David Askmyr, Malin Lindstedt, , Carlos‐Filipe Pereira

This study reprograms tumor cells in vivo to function as dendritic cells, leading to tumor regression and long-term immunity in mouse models.

Science · Aug 1, 2024Peer-reviewedImmunology